Anticoagulants Safe With Enzyme-Inducing Meds for EpilepsyJanuary 5, 2024Acute Coronary SyndromesArrhythmias & EP
Antithrombotic therapy not warranted in COVID-19 outpatientsOctober 25, 2021Acute Coronary SyndromesDVT/VTE
Digital alerts reduced AF-related stroke, MI ratesDecember 18, 2018Arrhythmias & EPAcute Coronary Syndromes
Alteplase, aspirin provide similar functional outcomes after nondisabling strokeJuly 10, 2018Acute Coronary Syndromes
New look at ATLAS suggests rivaroxaban may still have role in ACSJuly 2, 2018Arrhythmias & EPDVT/VTEAcute Coronary Syndromes
First reversal agent for apixaban and rivaroxaban gets fast-track approvalMay 4, 2018Arrhythmias & EPAcute Coronary Syndromes
Women’s representation in CV drug trials still laggingApril 30, 2018Acute Coronary SyndromesArrhythmias & EP
MI before age 50? Think familial hypercholesterolemia, substance abuseApril 26, 2018Acute Coronary Syndromes
ODYSSEY Outcomes trial redefines secondary cardiovascular preventionMarch 10, 2018Acute Coronary Syndromes
